Apyx Medical Forecasts FY23 Revenues Of $53M-$54M Compared To Prior Guidance Of $59M-$62M And Consensus Of $59.68M
Portfolio Pulse from Benzinga Newsdesk
Apyx Medical has revised its FY23 revenue forecast to $53M-$54M, down from its previous guidance of $59M-$62M and consensus of $59.68M. This represents a growth of 19% to 21% compared to the total revenue of $44.5 million for the year ended December 31, 2022.
November 09, 2023 | 12:21 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
Apyx Medical has lowered its FY23 revenue forecast, which could negatively impact investor sentiment and potentially lead to a decrease in the company's stock price in the short term.
Apyx Medical's revised FY23 revenue forecast is lower than its previous guidance and consensus estimates. This could be perceived negatively by investors, potentially leading to a decrease in the company's stock price in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100